Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-5920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay ; volume:19 ; number:1 ; day:6 ; month:4 ; year:2021 ; pages:1-10 ; date:12.2021
Journal of Genetic Engineering and Biotechnology ; 19, Heft 1 (6.4.2021), 1-10, 12.2021
- Creator
-
Swellam, Menha
Saad, Entsar A.
Sabry, Shimaa
Denewer, Adel
Abdel Malak, Camelia
Abouzid, Amr
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43141-021-00154-x
- URN
-
urn:nbn:de:101:1-2021052820313560717236
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Swellam, Menha
- Saad, Entsar A.
- Sabry, Shimaa
- Denewer, Adel
- Abdel Malak, Camelia
- Abouzid, Amr
- SpringerLink (Online service)
Other Objects (12)
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
SMAD4 Y353C promotes the progression of PDAC
Differentielle Genexpressionsanalyse von Smad4-defizienten Pankreaskarzinomzelllinien nach Reexpression von Smad4
Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
Role of SMAD4 missense mutations in colorectal cancer progression
Integrated multi-omics characterization of SMAD4 mutant colorectal cancer
A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Identification of Smad4-interacting proteins using yeast two-hybrid screening
Characterisation of microglia-specific Tgfbr2, Smad4 and Tgfb1 knockout mice
Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
SMAD4 Y353C promotes the progression of PDAC
Differentielle Genexpressionsanalyse von Smad4-defizienten Pankreaskarzinomzelllinien nach Reexpression von Smad4
Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
Role of SMAD4 missense mutations in colorectal cancer progression
Integrated multi-omics characterization of SMAD4 mutant colorectal cancer
A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Identification of Smad4-interacting proteins using yeast two-hybrid screening
Characterisation of microglia-specific Tgfbr2, Smad4 and Tgfb1 knockout mice
Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
SMAD4 Y353C promotes the progression of PDAC
Differentielle Genexpressionsanalyse von Smad4-defizienten Pankreaskarzinomzelllinien nach Reexpression von Smad4
Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
Role of SMAD4 missense mutations in colorectal cancer progression
Integrated multi-omics characterization of SMAD4 mutant colorectal cancer
A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Identification of Smad4-interacting proteins using yeast two-hybrid screening
Characterisation of microglia-specific Tgfbr2, Smad4 and Tgfb1 knockout mice